7Baggers
 Annovis Reports New Biomarker Data Linking Amyloid  GlobeNewswire Mon, 17 Nov 2025 13:00:00 GMT
 Annovis Bio Inc. Reports Q3 2025 Financial Results  TipRanks Thu, 13 Nov 2025 04:17:34 GMT
 annovis bio ceo maccecchini buys $200k in company stock by investing.com  Investing.com Nigeria Thu, 13 Nov 2025 03:40:44 GMT
 Insider Stock Purchases: November 12, 2025  Quiver Quantitative Wed, 12 Nov 2025 18:45:00 GMT
 Annovis Bio Stock (ANVS) Opinions on Phase 3 Alzheimer’s Trial Progress  Quiver Quantitative Wed, 12 Nov 2025 17:32:00 GMT
 Annovis Bio CEO Maccecchini buys $200k in company stock  Investing.com Wed, 12 Nov 2025 14:45:24 GMT
 Annovis Bio sees cash runway to 3Q26  TipRanks Wed, 12 Nov 2025 13:56:17 GMT
 Annovis Bio reports Q3 EPS (37c) vs. (97c) last year  TipRanks Wed, 12 Nov 2025 13:14:07 GMT
 ANVS - Annovis Bio Inc Latest Stock News & Market Updates  Stock Titan Wed, 12 Nov 2025 13:00:00 GMT
 Annovis Bio Receives Non-Compliance Notice from NYSE  MSN Wed, 12 Nov 2025 07:21:34 GMT
 Annovis Bio’s phase 3 Alzheimer’s trial reaches 25% completion  Investing.com Thu, 06 Nov 2025 08:00:00 GMT
 annovis bio (nyse:anvs) shares down 3.7% - here's what happened  MarketBeat Tue, 04 Nov 2025 07:30:45 GMT

Annovis Bio, Inc
(NYSE:ANVS) 

ANVS stock logo

Annovis Bio, Inc., a clinical stage drug platform company, develops drugs to treat neurodegeneration. The company's lead compound is ANVS401, which is in Phase 2a clinical trials for the treatment of Alzheimer's disease (AD), Parkinson's disease, Alzheimer's disease in Down Syndrome, and other chron...

Founded: 2008
Full Time Employees: 2
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends